Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (8): 949-954.
DOI: 10.19803/j.1672-8629.20240249
Previous Articles Next Articles
SUN Li1, XIE Bin1,2, XU Yanqin2,*
Received:
2024-04-18
Online:
2024-08-15
Published:
2024-08-21
CLC Number:
SUN Li, XIE Bin, XU Yanqin. Research progress of sustained and controlled release preparations of Chinese medicine[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
[1] QIU CY.Study on the academic experience of professor Wu Bingcai in the application of pills[D]. Nanchang: Jiangxi University of Chinese Medicine, 2023. [2] LI WM, ,YU Q, XU BL, et al. Research progress of sustained and controlled release preparations of Chinese medicine[J]. Chinese Medicine Modern Distance Education of China(中国中医药现代远程教育), 2023, 21(1): 200-203. [3] FANG RH, YANG ZQ, LI BS, et al.Research progress of targeted treatment of brain diseases with Chinese medicine nanotechnology[J].Chinese Journal of Comparative Medicine(中国比较医学杂志), 2023, 33(6): 128-140. [4] ZHAO JH, LlU YY, YAO D, et al. Research progress of solid lipid nanoparticles and nanostructure lipid carriers[J/OL]. China Oils and Fats(中国油脂), (2023-07-27)[2024-03-14]. https://doi.org/10.19902/j.cnki.zgyz.1003-7969.230028. [5] GHASEMIYEH P, SOLIMAN MS.Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages[J]. Res Pharmaceut Sci, 2018, 13(4): 288-303. [6] LIU JH, SUN LJ.Applications of lipid nanoparticles in treating skin diseases in transdermal drug delivery system[J].Guangdong Chemical Industry(广东化工), 2024, 51(6): 82-84. [7] CHEN XY, YUAN F, SHI KQ, et al.Recent advances of film coating for osmotic drug delivery systems[J].Chinese Pharmaceutical Journal(中国药学杂志), 2021, 56(23): 1874-1879. [8] SHENG XL, SONG XM, PENG J.Usage of sustained and controlled release preparations in a hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(10): 740-744. [9] ZENG Y, ZHU LQ, PENG Y, et al.Optimization of the prescription and preparation process of difenidol hydrochloride single-layer osmotic pump controlled-release tablets[J]. China Pharmaceuticals(中国药业), 2021, 30(9): 22-26. [10] PANG R, LI KY, WANG CY, et al.Preparation and in vivo pharmacokinetics of monolithic osmotic pump tablets of ursolic acid solid dispersions[J].Chinese Traditional Patent Medicine(中成药), 2022, 44(7): 2088-2093. [11] LI YJ, ZHOU J.Preparation and optimization of brucine push-pull osmotic pump controlled release tablets formulation[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2019, 36(22): 2805-2809. [12] ZHANG XQ.Study on the preparation process of gastric floating slow release tablets for the relief of alcohol[D]. Harbin: Harbin University of Commerce, 2023. [13] GENG YN, LOU TT, WU YJ, et al.Preparation of floating eucommia ulmoides tablets for pulsatile release[J]. China Pharmaceuticals(中国药业), 2020, 29(7): 82-86. [14] RAHAMATHULLA M, SAISIVAM S, GANGADHARAPPA HV.Development of valsartan floating matrix tablets using low density polypropylene foam powder: in vitro and in vivo evaluation[J]. Aaps Pharmscitech, 2019, 20(1): 35. [15] ZHANG PC, FANG D, HAO HJ, et al.Preparation of evodiamine gastric floating tablets and their protective effects on rabbitgastric mucosa injury[J]. Chinese Traditional Patent Medicine(中成药), 2023, 45(11): 3527-3533. [16] HUANG ZY, FANG D, HAO HJ, et al.Preparation and evaluation of gastric floating tablets of Costunolide and Dehydrocostus lactone and study of drug release mechanism[D]. Chengdu: Chengdu University of Traditional Chinese Medicine, 2022. [17] LIU W, LIU W, SONG XL, et al.Preparation and quality evaluation of breviscapine gastric adhesive tablets[J]. China Pharmacy(中国药房), 2020, 31(14): 1690-1694. [18] AN Y, JIA L, LI L, et al.Preparation technology and in vitro properties of curcumin bioadhesive microspheres[J]. Journal of Heze Medical College(菏泽医学专科学校学报), 2020, 32(4): 88-91. [19] LUO WQ.Study on the scale-up preparation of acyclovir-loaded bioadhesive microspheres[D]. Shanghai: Fudan University, 2012. [20] ZHANG XY, YING ZH, GUO SB, et al.Research progress on preparation techniques and quality control of solid dispersions[J]. China Powder Science and Technology(中国粉体技术), 2024, 30(2): 96-112. [21] SONG XL, YANG DB, WANG YL, et al.Optimizing preparation technology of strychnos alkaloids microcapsules by central composite design-response surface method[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2018, 33(4): 1582-1587. [22] MA QB, GAO JW, ZHU XJ, et al. Optimization of preparation technology of angelica oil microcapsules by Box-Behnken response surface methodology and quality evaluation[J/OL]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), (2024-04-21)[2024-07-31]. http://kns.cnki.net/kcms/detail/21.1546.R.20240419.1350.022.html. [23] QIU K, ZHOU LM, WANG S, et al.Preparation and quality evaluation of panax notoginseng saponins multivesicular liposomes[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2023, 58(24):2259-2266. [24] DENG XT, HAO HJ, HAN R, et al.Preparation technique of monolithic osmotic pump tablet containing inclusion complex of baicalein[J]. Academic Journal of Second Military Medical University(第二军医大学学报), 2015, 36(5): 513-517. [25] PANG R, LI KY, WANG CY.Preparation and in vivo pharmacokinetics of monolithic osmotic pump tablets of ursolicacid solid dispersions[J].Chinese Traditional Patent Medicine(中成药), 2022, 44(7): 2088-2093. [26] LI K, HE XX, HE ZL, et al.Preparation, quality evaluation and therapeutic effect of pseudolaric acid B liposome gel in mice with atopic dermatitis[J]. Chinese Journal of New Drugs(中国新药杂志), 2022, 31(16): 1623-1630. [27] TU Q, JIAN YY, XIE DM, et al.Preparation and physicochemical properties of cinnamon essential oil liposomes[J]. Food and Fermentation Industries(食品与发酵工业), 2023, 49(17): 194-201. [28] WANG FJ, LONG J, GAO N, et al.Study on preparation process of chelidonium majus total alkaloid sustained-release tablets[J].Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2024, 33(4): 13-17. [29] LIN QW, ZHONG HL, LI PB, et al.Preparation of berberine hydrochloride enteric-coated sustained release tablets[J]. Journal of Pharmaceutical Research(药学研究), 2022, 41(5): 307-311. [30] LU DY.Preparation and quality evaluation of ligustrazine phosphate sustained-release pellets[D]. Nanchang: Jiangxi University of Chinese Medicine, 2021. [31] LI CM, SHI TH, CHEN X, et al.Preparation process optimization and in vitro and in vivo properties of sanguinarine chitosan microspheres[J]. Special Wild Economic Animal and Plant Research(特产研究), 2024, 46(2): 36-46. [32] CHEN C, DONG YS, LI WZ, et al.Preparation and quality evaluation of porous drug-loaded microsphere based on Bletilla striata polysaccharide[J]. Chemical Engineer(化学工程师), 2023, 37(9): 1-4. [33] LI N, DENG YP.Preparation of solid lipid nanoparticles loaded with emodin based on quality by design principles[J]. Chinese Traditional and Herbal Drugs(中草药), 2024, 55(7): 2216-2226. [34] LIU XJ.Antibacterial, anti-inflammatory function evaluation and preparation of microemulsion gel of essential oil from chrysanthemum stem and leaf and its compatible prescription[D]. Nanjing: Nanjing University of Chinese Medicine, 2022. [35] HUANG ZT, ZHANG SY, CHANG JH, et al.Preparation and in vitro dissolution determination of luteolin solid dispersion with different vehicles[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2023, 43(5): 494-500. [36] ZHANG PC, FANG D, HAO HJ.Preparation of evodiamine gastric floating tablets and their protective effects on rabbit gastric mucosa injury[J]. Chinese Traditional Patent Medicine(中成药), 2023, 45(11): 3527-3533. [37] XU ZJ.Preparation of imperatorin solid dispersion hydrogel matrix sustained-release tablets and pharmacokinetic evaluation[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(17): 5321-5329. [38] TANG LR, WANG Q, LIU WJ, et al.Preparation and in vitro synchronous release of modified Maijunan liposome tablets[J]. Journal of Hubei University(Natural Science)(湖北大学学报自然科学版), 2022, 44(1): 106-112. [39] ZHANG K, CHEN SS, WU L, et al.Preparation of bioerodible matrix sustained-release tablets of hawthorn leaf flavonoids[J]. Chinese Traditional Patent Medicine(中成药), 2014, 36(8): 1640-1643. [40] HU CX, YAN W, FAN MS.Formulation optimization for controlled release push-pull osmotic pump tablets of imperatorin[J]. Chinese Traditional Patent Medicine(中成药), 2022, 44(1): 13-18. [41] SHAO L, SUN L, FENG M, et al.In vivo release research of panax notoginseng saponins floating sustained-release tablets in rabbits[J]. Journal of Hubei University of Chinese Medicine(湖北中医药大学学报), 2017, 19(6): 46-49. [42] MA XT, XIAO FQ, QIU MY, et al.Optimization of water extraction andethanol precipitation process and activity of compound lipid-lowering sustained-release tablets by multi-index comprehensive scoring method[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(17): 1759-1765. [43] CAI YQ, LI BY, ZHONG XY, et al.Study on shedding particles from chuanping sustained-release tablets based on multi-marker components balanced release[J]. Chinese Traditional and Herbal Drugs(中草药), 2019, 50(4): 836-843. [44] GAO XM, ZOU GX, XIN XY, et al.Pharmacokinetics of puerarin in guanmaikang sustained-release capsule in beagle dogs[J]. Journal of Liaoning University of TCM(辽宁中医药大学学报), 2019, 21(4): 44-46. [45] GUO H, CHEN XM, DUAN ZH.Study on the pharmacokinetics and relative bioavailability of enteric sustained-release capsule of oxymatrine phospholipid complex in mice[J]. Journal of Shandong University of TCM(山东中医药大学学报), 2017, 41(5): 482-485. [46] CHEN J, ZHAO XQ, MA YQ, et al.Preparation and in vitro transdermal permeation of zedoary turmeric oil compound liposomes gel[J]. Chinese Journal of New Drugs(中国新药杂志), 2018, 27(7): 830-838. [47] GUAN QX, WEN MX, LIU ZQ, et al.Tissue distribution of brucine-loaded solid lipid nanoparticles in mice in vivo[J]. Chinese Traditional Patent Medicine(中成药), 2017, 39(4): 714-718. [48] LIU MY.Preparation and in vivo pharmacokinetic study of matrine pellets as a colon-targeting sustained release system[D]. Yinchuan: Ningxia Medical University, 2014. [49] ZHANG T.The study on PK-PD sustained release evaluation of Ganershu pellets[D]. Naijing: Naijing University of Chinese Medicine, 2013. [50] LAI HQ, HU Y, LI XD.The in vitro dissolution of total composition of the tablet of rhizomes of Ligusticum chuanxiong components and in vitro-in vivo correlation by the method of area under the absorbance-wavelength curve[J]. Acta Pharmaceutica Sinica(药学学报), 2015, 50(6): 788-792. [51] LUO Y.Studies on the drug release kinetics in vitro and vivo of Chuangping sustained-release pellets[D]. Guangzhou: Guangdong Pharmaceutical University, 2014. |
[1] | SUN Yue, HU Xinyue, LI Jing, ZHANG Wei, DING Xiaoli, ZHANG Hui, LIANG Chenggang. Quality evaluation of desmopressin tablets and injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 632-637. |
[2] | DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan. Quality evaluation of insulin glargine injections [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650. |
[3] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Roles of Yangxue Antai prescription in improving endometrial epithelial-mesenchymal transformation and decidualization in recurrent spontaneous abortion mice by regulating autophagy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 547-552. |
[4] | LI Yao, CHEN Yuxin, GAO Haiyun, LI Hui, LIU Tianrui, YUAN Yuan. Analysis of prescription rules for Omphalia lapidescens based on the Dictionary of Chinese Traditional Medicine Prescriptions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 553-558. |
[5] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Effect of Yangxue Antai prescription on the regulation of placental angiogenesis and autophagy in recurrent spontaneous abortion mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 371-377. |
[6] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Study on the mechanism of Yangxue Antai prescription regulating autophagy in the treatment of recurrent spontaneous abortion mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 378-385. |
[7] | LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli. Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427. |
[8] | ZHOU Yue, LIU Shuo, SONG Haibo. Roles of licensed pharmacists in drug classification management [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 428-434. |
[9] | SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian. Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903. |
[10] | SU Yuefen, ZHENG Jingrou, GONG He, XIE Guangtong, ZHANG Jie, SAI Chunmei. Formability and mechanism of breast nodule pain-alleviating gel plaster for the treatment of breast hyperplasia [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 783-790. |
[11] | ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong. Pharmacist-led practice in the management of elderly patients with polypharmacy [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821. |
[12] | WANG Yadan, YAN Jiangong, CHEN Minghui, PANG Yu, DAI Zhong, MA Shuangcheng. UPLC fingerprints of tripterygium glycosides tablets from different manufacturers [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 146-151. |
[13] | YIN Jinjun, WANG Shuwei, SHAO Jiangchao, WANG Bing. Drug use evaluation of bevacizumab injection based on weighted TOPSIS method [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1421-1426. |
[14] | LIU Kecheng, WEI Tanjun, CHEN Fei, XIAO Cheng, ZHANG Yinsu. Quality evaluation of Chaihu Shugan granules ria multi-component quantification combined with GRA and EW-TOPSIS method [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1243-1248. |
[15] | LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong. Applicability of PDCA cycle in standardization of outpatient prescriptions [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||